Learning Objectives:

 1. Understand the incidence of vestibular schwannoma in the US and European population.
 2. Elucidate the differences in patient reported quality of life in patients with vestibular schwannoma undergoing a variety of treatments.
 3. Review tools available to predict future loss of hearing or other adverse effects in patients with vestibular schwannoma.
Session date: 
11/08/2023 - 7:30am to 8:30am CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Michael Link, MD